Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,507
New position
Shares Held
16
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#641
of 649 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monetary Solutions, Ltd holds $3,711,271 across 15 Drug Manufacturers - General names. NVS ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
7,687 | $1,934,356 | |
| 2 | JNJ |
Johnson & Johnson
|
4,268 | $1,083,943 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,049 | $263,296 | |
| 4 | LLY |
ELI LILLY & Co
|
130 | $155,925 | |
| 5 | AMGN |
Amgen Inc
|
359 | $130,001 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,400 | $80,668 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
416 | $52,557 | |
| 8 | NVS |
Novartis AG
This page
|
16 | $2,507 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,507 | 16 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||